梅州微创可视打胎咨询梅州治女性疾病的医院哪个好,梅州微管可视无痛人流手术要注意什么,梅州那里可以做眼袋,梅州女性打胎的费用要多少钱,梅州怀孕一个月人流总费用,梅州引起非特异性阴道炎的原因,梅州处女膜修补的方法是什么

MOSCOW, June 15 (Xinhua) -- Russia's Mission Control announced on Wednesday it had raised the International Space Station (ISS) by 10.2 km to 374.7 km with the help of the Europe's ATV-2 Johannes Kepler.The Mission Control conducted the correction to the ISS at 19: 55 Moscow time (1555 GMT) by the boosters of the ATV-2 Johannes Kepler. The correction had lasted for some 40 minutes.According to the Mission Control, the correction was made in line with the ISS's ballistic flight program.On June 12, the Europe's second Automated Transfer Vehicle (ATV) Johannes Kepler has conducted two similar operations, raising the ISS orbit by 19.2 km to 364.6 km.Corrections to the space station's orbit are conducted periodically before launches of Russian cargo ships and U.S. shuttles to compensate for the Earth's gravity and to safeguard successful dockings.According to the Mission Control, the ATV-2 Johannes Kepler is scheduled to undock from the ISS on June 21.

VIENNA, Sept. 9 (Xinhua) -- The three-day Traditional Chinese Medicine (TCM) exhibition opened Friday in the Flower Garden Hirschstetten in Vienna, with the aim to introduce traditional Chinese medicine to the Austrians and to arouse their interest in the culture of Chinese medicine.Holding for the second time, the exhibition this year have attracted more visitors to take part in the health talks on traditional Chinese medicine, read or buy books around the theme of traditional Chinese medicine. Some visitors enthusiastically tried Chinese diet therapy prepared by the organizers.In recent years, traditional Chinese medicine has been increasingly recognized and accepted in Austria. It has already not only entered into the classroom but also into the hospital and clinic.Some private health insurance companies in Austria have started to include the treatment by traditional Chinese medicine into their insuring categories. Chinese patent drugs are already available in many pharmacies in Austria.But in general, traditional Chinese medicine still faces many limits in Austria, which hasn't been involved into the public health insurance system. Some Austrians still have doubts of Chinese medicine, in particular the medicinal herb drugs. All these have restricted the development of traditional Chinese medicine here.Currently, major clinics of traditional Chinese medicine carry out only acupuncture and moxibustion, massage and other health-care physical therapy.Richard Schmerker, a doctor of traditional Chinese medicine in Austria, told reporters that the development of traditional Chinese medicine here still faces many challenges and the biggest one is the shortage of effective propaganda and popularization.But he expressed his full confidence about the future of traditional Chinese medicine in Austria. He said, the uniqueness of finding the root cause of diseases and laying the axe to the root will make it be accepted by more and more Austrians.

WELLINGTON, June 7 (Xinhua) -- Scientists in New Zealand have developed a new drug to fight previously untreatable hypoxic cancer tumors, which form in areas of the body starved of oxygen.The researchers at the Auckland University have entered an agreement for the clinical development of CEN-209, which was developed over 10 years of research, said a statement from the university Tuesday.CEN-209 was designed to enhance the effectiveness of radiotherapy and chemotherapy in solid hypoxic tumors, which were resistant to standard cancer therapies, said the statement. In lung cancer patients for example, about half of tumors had hypoxic regions.The new drug worked by damaging the DNA of hypoxic cancer cells, while leaving normal, healthy tissues alone.CEN-209 was designed and created by researchers at the university's Auckland Cancer Society Research Centre (ACSRC), using computer models of drug transport within tumors to accurately predict the anti-tumor activity of the drugs."Our computer models of drug transport developed in-house allowed the synthetic chemists to test their design theories and considerably shortened the discovery process," said Associate Professor Michael Hay, who led the ACSRC research chemists."CEN-209 improves markedly on previous agents in this class in terms of its ability to penetrate tumors, and this is reflected by its improved activity in the laboratory, when combined with long or short courses of radiotherapy," said researcher Professor Bill Wilson.Under the agreement between the university's Auckland UniServices Ltd. and California-based Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc., Centella will have exclusive rights to CEN-209, which it will develop and trial with Cancer Research UK.The work on CEN-209 is the culmination of a program initiated with funding from the U.S. National Cancer Institute, and more recently from the Maurice Wilkins Centre for Biodiscovery. Ongoing preclinical research on CEN-209 and a backup compound was funded by grants from the Auckland Medical Research Foundation, Genesis Oncology Trust and Health Research Council of New Zealand, said the statement.

BEIJING, July 26 (Xinhuanet) -- Hong Kong scientists announced that they had determined the idea of time travel is impossible by proving nothing can travel faster than the speed of light.The finding is contained in a study done by a research team from Hong Kong University of Science and Technology. The study was published Monday in a scientific journal "Physical Review Letters" in the United States."The study, which showed that single photons also obey the speed limit c, confirms Einstein's causality, that is, an effect cannot occur before its cause," the university said on its website."By showing that single photons cannot travel faster than the speed of light, our results bring a closure to the debate on the true speed of information carried by a single photon." said Professor Du Shengwang, who led the study.The possibility of time travel was raised 10 years ago when scientists discovered the optical pulses in some specific medium might propagate information in a faster-than-light speed."Our findings will also likely have potential applications by giving scientists a better picture on the transmission of quantum information." Du said.

BEIJING, Aug. 30 (Xinhuanet) -- The search giant Google admits it sees the new Google+ social network as an "identity service" or platform on which it can build other products, according to media reports.Google chariman Eric Schmidt said Google isn't interested in changing its policies to accommodate users such as political dissidents or others who prefer to remain anonymous: If people want to remain anonymous, then they shouldn't use Google+."Fundamentally, [Google+] depends on people using their real names if they're going to build future products that leverage that information," NPR's Andy Carvin wrote in a post on Google+ as he paraphrased Schmidt's remarks.Critics say the move is harmful to political activists, victims of harassment and numerous other groups for whom using a real name online might pose a safety risk, according to CNN reports."Regarding people who are concerned about their safety, [Schmidt] said G+ is completely optional," Carvin wrote.Meanwhile, according to Carvin, Schmidt also said "the Internet would be better if we knew you were a real person rather than a dog or a fake person. Some people are just evil and we should be able to ID them and rank them downward."